… of patients with rheumatic heart disease had positivity for anti-… the M protein in 16.6% of
cases. The authors concluded that … Valvular heart disease in primary antiphospholipid syndrome …

… AMI) with nonobstructive coronary artery disease accounts for five to … cases (45%), AMI
presented as ST-segment elevation. They found this in 75% of the cases presented with coronary …

… The occurrence of AMI in patients with APS has been identified from the first descriptions
of the disease, as coronary artery disease can often be the first manifestation of this …

… patients without coronary heart disease, but NMD was reduced only in aCL-positive patients
[103], which might reveal that the decreased FMD is a satisfactory marker of CVD in APS. …

… cohorts of patients using these cutting-edge approaches holds the … cardiovascular disease
in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome …

… , chronic kidney disease, and coronary artery disease, coupled … and four cases of major
bleeding were described [54]. … life-threatening variant of antiphospholipid syndrome (APS), is …

… in Manchester; in the present paper we report the most important advances on these issues.
… Another cutting-edge approach exploits a monoclonal antibody, named MBB2ΔCH2, which …

… cutting-edge diagnostic tools and therapeutic strategies. … for venous thromboembolism and
cardiovascular disease, with … while also adding cardiac valve disease and thrombocytopenia …

… mTOR is a phosphatidylinositol kinase which plays a crucial role in multiple metabolic
pathways, and increased mTOR activity has been related to cardiovascular diseases and …

… of atherosclerotic cardiovascular disease, heart failure, atrial … the success rate in treating
cardiovascular diseases, and can … not minimizing its ethical and legal issues [11]. This summary …